Deep vein thrombosis (DVT) is primarily treated with blood-thinning medications called anticoagulants, which stop the clot from growing and prevent new clots from forming while your body gradually dissolves the existing one. Most people start treatment immediately after diagnosis, and the majority can be treated at home rather than in a hospital. The type of medication, how long you take it, and whether you need additional procedures all depend on where the clot is, what caused it, and your overall health.
Blood Thinners Are the Standard Treatment
Anticoagulants are the cornerstone of DVT treatment. For most people, this means a type of oral medication known as a direct oral anticoagulant, or DOAC. These have largely replaced the older standard, warfarin, because they don’t require regular blood tests to monitor and have fewer interactions with food and other medications.
The two most commonly prescribed DOACs for DVT work slightly differently in terms of schedule. One option starts at a higher dose twice daily for the first seven days, then drops to a lower maintenance dose twice daily. The other starts at a higher dose twice daily for three weeks, then switches to a once-daily dose. Both approaches front-load a stronger dose to aggressively slow clot growth in the critical early period, then taper down for ongoing protection.
Warfarin is still used in certain situations, particularly for people with severe kidney disease or specific clotting conditions where DOACs aren’t appropriate. If you’re on warfarin, you’ll need regular blood draws to check your clotting time (called INR) and adjust your dose accordingly. This can mean weekly or biweekly lab visits, especially early on.
The risk of serious bleeding while on blood thinners is real but relatively low. During the first six months of treatment, roughly 1 in 100 patients experiences a major bleeding event. After six months, that rate drops to about 0.7% among those who continue treatment. Your care team will weigh this bleeding risk against the risk of another clot when deciding how long to keep you on medication.
How Long Treatment Lasts
Treatment duration hinges on one critical question: what triggered the clot? DVT caused by a temporary, identifiable trigger, like surgery, a broken bone, or a long period of immobility, is called “provoked.” DVT that happens without a clear cause is “unprovoked.”
For both provoked and unprovoked DVT, the initial treatment course is typically three to six months. The American Society of Hematology recommends this shorter course over longer initial treatment of six to twelve months, based on the evidence that the shorter duration is equally effective at treating the acute clot.
The bigger decision comes after that initial course ends. If your DVT was provoked by a temporary risk factor, like recovering from surgery, you’ll generally stop anticoagulation once the three-to-six-month course is complete. The trigger is gone, and your risk of recurrence is low. But if your DVT was unprovoked, or was provoked by an ongoing risk factor like cancer or an autoimmune condition, guidelines suggest staying on blood thinners indefinitely. The reasoning is straightforward: if the underlying risk hasn’t gone away, neither has the chance of another clot.
For people who’ve had a recurrent unprovoked DVT, the recommendation is even stronger. Indefinite anticoagulation becomes a firm guideline rather than a suggestion. On the other hand, if you’ve had two DVTs that were both triggered by temporary risk factors (say, two separate surgeries years apart), stopping treatment after the primary course is generally reasonable.
Moving Around After Diagnosis
One of the most common concerns after a DVT diagnosis is whether it’s safe to walk and move around. The old approach was strict bed rest for at least several days, based on the fear that movement would dislodge the clot and send it to the lungs. That thinking has been overturned.
A meta-analysis comparing bed rest to early walking (within three days of diagnosis) found that getting up and moving did not increase the risk of a blood clot traveling to the lungs, did not cause the DVT to worsen, and did not increase DVT-related deaths. Patients who walked early actually had better pain relief than those who stayed in bed, particularly those who started with moderate to severe leg pain. The American College of Chest Physicians now recommends early movement under feasible circumstances once anticoagulation has been started.
When More Aggressive Treatment Is Needed
Most DVTs respond well to anticoagulation alone. But in specific situations, a procedure called catheter-directed thrombolysis may be used. This involves threading a thin tube into the vein and delivering clot-dissolving medication directly to the blockage.
This approach is generally reserved for a narrow group: younger patients (under 65), with clots in the large veins of the upper thigh and pelvis (iliofemoral DVT), who have significant symptoms, low bleeding risk, and were previously active. Clots limited to the veins below the groin, in the thigh or behind the knee, rarely warrant this procedure.
The one scenario where catheter-directed treatment becomes urgent is a rare condition called phlegmasia cerulea dolens, where the clot is so extensive that it threatens blood supply to the entire limb. The leg becomes severely swollen, blue, and painful. This is a medical emergency requiring immediate intervention unless the bleeding risk is prohibitive.
For patients with less severe iliofemoral DVT, some specialists recommend trying anticoagulation alone for five to seven days first, monitoring symptoms closely, and escalating to a catheter procedure only if symptoms worsen. The primary benefit of thrombolysis is symptom relief in the first six months rather than long-term clot prevention, so the decision often comes down to how much the clot is affecting daily function.
IVC Filters: A Safety Net, Not a Treatment
An inferior vena cava (IVC) filter is a small, cage-like device placed inside the large vein that carries blood from your lower body back to your heart. Its job is to catch clot fragments before they reach the lungs. It doesn’t treat the DVT itself.
Major guidelines from the American Heart Association, the American College of Chest Physicians, and other organizations recommend IVC filters in three specific situations: when you have DVT but absolutely cannot take blood thinners, when complications force you to stop anticoagulation, or when you develop new clots despite being properly anticoagulated. Most modern filters are retrievable, meaning they can be removed once you’re able to resume blood thinners safely.
Preventing Long-Term Leg Problems
After a DVT, many people develop lasting symptoms in the affected leg: swelling, aching, heaviness, skin changes, or in severe cases, ulcers. This is called post-thrombotic syndrome (PTS), and it happens because the clot damages the valves inside the vein that normally keep blood flowing upward.
Compression stockings have long been recommended to reduce PTS risk. Earlier studies suggested they could cut the risk by as much as 50% when using stockings with at least 30 mmHg of ankle pressure, worn from waking to bedtime for two years. However, a large, more rigorously designed trial found no benefit, leaving the evidence genuinely mixed. Some physicians still recommend them, particularly if you have significant leg swelling or discomfort, but they’re no longer considered mandatory for every DVT patient. If you do use them, consistent daily wear appears to be key.
Traveling After a DVT
If you’re planning air travel after a DVT diagnosis, timing matters. The International Air Travel Association says you can fly once you’re asymptomatic and stable on your blood thinner. The British Thoracic Society is more specific, recommending a minimum two-week delay after diagnosis before flying. On long flights, staying hydrated, moving your legs regularly, and wearing compression stockings can help reduce the risk of a new clot forming during travel.